Clincosm LogoSign in Get a demo

colorectal cancer

Showing NaN - NaN of 206
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial in Worldwide (favezelimab/pembrolizumab, regorafenib, TAS-102)

Active, not recruiting
  • Colorectal Cancer
  • favezelimab/pembrolizumab
  • +2 more
  • Washington, District of Columbia
  • +151 more
Oct 12, 2022

Colorectal Cancer Trial in New York (mAb hu3S193)

Terminated
Has Results
  • Colorectal Cancer
  • monoclonal antibody hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Possible Effects of Medication on Young Onset Colorectal Cancer

Recruiting
  • Colorectal Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 4, 2022

    Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

    Recruiting
    • Solid Tumor
    • +11 more
    • TRK-950
    • +14 more
    • Scottsdale, Arizona
    • +13 more
    Oct 2, 2022

    Colorectal Cancer, Cholangiocarcinoma Trial in United States (Medtronic pump and Codman catheter, Floxuridine (FUDR),

    Active, not recruiting
    • Colorectal Cancer
    • Cholangiocarcinoma
    • Medtronic pump and Codman catheter
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Oct 3, 2022

    Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

    Recruiting
    • Breast Cancer
    • +15 more
    • ATRC-101
    • +2 more
    • Phoenix, Arizona
    • +10 more
    Sep 28, 2022

    Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

    Completed
    • Melanoma
    • +25 more
    • Scottsdale, Arizona
    • +10 more
    Sep 27, 2022

    Reproductive and Sexual Health in People With Early Onset

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Hormone biomarker analysis
    • QoL Questionnaires
    • Hartford, Connecticut
    • +7 more
    Sep 8, 2022

    Breast Cancer, Prostate Cancer, Colorectal Cancer Trial in United States (Exercise)

    Recruiting
    • Breast Cancer
    • +11 more
    • Exercise
    • San Carlos, California
    • +7 more
    Aug 24, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)

    Active, not recruiting
    • Colorectal Cancer
    • Los Angeles, California
    • +12 more
    Aug 19, 2022

    Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

    Active, not recruiting
    • Advanced Solid Tumors
    • +7 more
    • Duarte, California
    • +87 more
    Aug 19, 2022

    Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

    Recruiting
    • Neoplasm Malignant
    • +5 more
    • Duarte, California
    • +55 more
    Aug 17, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Colorectal Cancer, MSS, Stage IV Colon Cancer Trial in Belgium, Switzerland, United States (ATP128, BI 754091, VSV-GP128)

    Recruiting
    • Colorectal Cancer
    • +5 more
    • Scottsdale, Arizona
    • +10 more
    Aug 15, 2022

    Colorectal Cancer, Triple Negative Breast Cancer, Gastric Cancer Trial in United States (navicixizumab+paclitaxel,

    Recruiting
    • Colorectal Cancer
    • +3 more
    • navicixizumab+paclitaxel
    • +2 more
    • Hot Springs, Arkansas
    • +5 more
    Aug 9, 2022

    Colorectal Cancer Trial in Worldwide (Regorafenib, Atezolizumab, Imprime PGG)

    Recruiting
    • Colorectal Cancer
    • Duarte, California
    • +17 more
    Aug 3, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Colorectal Cancer, Healthy, no Evidence of Disease Trial in Buffalo, New York (behavioral intervention)

    Completed
    • Colorectal Cancer
    • Healthy, no Evidence of Disease
    • behavioral intervention
    • Buffalo, New York
    • +1 more
    Jul 20, 2022

    Colorectal Cancer, Rectal Cancer, Rectal Tumor Trial in Belgium, France, United States (Colovac, Stoma Creation)

    Suspended
    • Colorectal Cancer
    • +3 more
    • Colovac
    • Stoma Creation
    • Los Angeles, California
    • +11 more
    Jul 18, 2022

    Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

    Recruiting
    • Pancreatic Cancer
    • +15 more
    • Grand Rapids, Michigan
    • +2 more
    Jul 18, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)

    Active, not recruiting
    • Colorectal Cancer
    • Metastatic Cancer
    • FOLFOX regimen
    • +7 more
    • New Brunswick, New Jersey
    • +1 more
    Jul 1, 2022

    Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

    Terminated
    • Melanoma
    • +6 more
    • Scottsdale, Arizona
    • +13 more
    Jun 24, 2022

    Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

    Recruiting
    • Ovarian Cancer
    • +10 more
    • West Hollywood, California
    • +27 more
    Jun 27, 2022